{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:06:58Z","timestamp":1791328018494,"version":"4.3.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,5,10]],"date-time":"2008-05-10T00:00:00Z","timestamp":1210377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1479-5876-6-24","type":"journal-article","created":{"date-parts":[[2008,5,10]],"date-time":"2008-05-10T06:13:35Z","timestamp":1210400015000},"source":"Crossref","is-referenced-by-count":75,"title":["Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer"],"prefix":"10.1186","volume":"6","author":[{"given":"Tetsuhiro","family":"Tsuruma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Iwayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tosei","family":"Ohmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Katsuramaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitake","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Furuhata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutoshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Torigoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Toyota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhito","family":"Yagihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Hirohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Shimozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,10]]},"reference":[{"key":"254_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/02841860310013391","volume":"42","author":"M Talback","year":"2003","unstructured":"Talback M, Stenbeck M, Rosen M, Barlow L, Glimelius B: Cancer survival in Sweden 1960\u20131998 \u2013 developments across four decades. Acta Oncol. 2003, 42: 637-659. 10.1080\/02841860310013391.","journal-title":"Acta Oncol"},{"key":"254_CR2","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/jnci\/dji289","volume":"97","author":"BK Edwards","year":"2005","unstructured":"Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW: Annual report to the nation on the status of cancer, 1975\u20132002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005, 97: 1407-1427.","journal-title":"J Natl Cancer Inst"},{"key":"254_CR3","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1002\/ijc.22160","volume":"119","author":"M Sant","year":"2006","unstructured":"Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F: Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer. 2006, 119: 2417-2422. 10.1002\/ijc.22160.","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"254_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S1120-1797(06)80011-6","volume":"21","author":"JR Gralow","year":"2006","unstructured":"Gralow JR: Breast cancer 2004: Progress and promise on the clinical front. Phys Med. 2006, 21 (Suppl 1): 2-10.1016\/S1120-1797(06)80011-6.","journal-title":"Phys Med"},{"key":"254_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0167-5699(97)80020-5","volume":"18","author":"T Boon","year":"1997","unstructured":"Boon T, Coulie PG, Eynde Van den B: Tumor antigens recognized by T cells. Immunol Today. 1997, 18: 267-268. 10.1016\/S0167-5699(97)80020-5.","journal-title":"Immunol Today"},{"key":"254_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1074-7613(00)80028-X","volume":"10","author":"SA Rosenberg","year":"1999","unstructured":"Rosenberg SA: A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity. 1999, 10: 281-287. 10.1016\/S1074-7613(00)80028-X.","journal-title":"Immunity"},{"key":"254_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S","volume":"80","author":"M Marchand","year":"1999","unstructured":"Marchand M, van Baren N, Weynants P, Brichard V, Dreno B, Tessier MH, Rankin E, Parmiani G, Arienti F, Humblet Y, Bourlond A, Vanwijck R, Lienard D, Beauduin M, Dietrich PY, Russo V, Kerger J, Masucci G, Jager E, De Greve J, Atzpodien J, Brasseur F, Coulie PG, Bruggen van der P, Boon T: Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer. 1999, 80: 219-230. 10.1002\/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S.","journal-title":"Int J Cancer"},{"key":"254_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nm0398-321","volume":"4","author":"SA Rosenberg","year":"1998","unstructured":"Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA, Einhorn JH, White DE: Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med. 1998, 4: 321-327. 10.1038\/nm0398-321.","journal-title":"Nat Med"},{"key":"254_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-3-1","volume":"3","author":"S Kawaguchi","year":"2005","unstructured":"Kawaguchi S, Wada T, Ida Y, Sato Y, Nagoya S, Tsukahara T, Kimura S, Sahara H, Ikeda H, Shimozawa K, Asanuma H, Torigoe T, Hiraga H, Ishii T, Tatezaki SI, Sato N, Yamashita T: Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma. J Transl Med. 2005, 3: 1-9. 10.1186\/1479-5876-3-1.","journal-title":"J Transl Med"},{"key":"254_CR10","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1840703","volume":"254","author":"P van der Bruggen","year":"1991","unstructured":"Bruggen van der P, Traversari C, Chomez P, Lurquin C, De Plasen E, Eynde Van den B, Knuth A, Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991, 254: 1643-1647. 10.1126\/science.1840703.","journal-title":"Science"},{"key":"254_CR11","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1073\/pnas.91.9.3515","volume":"91","author":"Y Kawakami","year":"1994","unstructured":"Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA: Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA. 1994, 91: 3515-3519. 10.1073\/pnas.91.9.3515.","journal-title":"Proc Natl Acad Sci USA"},{"key":"254_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1479-5876-2-19","volume":"2","author":"T Tsuruma","year":"2004","unstructured":"Tsuruma T, Hata F, Torigoe T, Furuhata T, Idenoue S, Kurotaki T, Yamamoto M, Yagihashi A, Ohmura T, Yamaguchi K, Katsuramaki T, Yasoshima T, Sasaki K, Mizushima Y, Minamida H, Kimura H, Akiyama M, Hirohashi Y, Asanuma H, Tamura Y, Shimozawa K, Sato N, Hirata K: Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer. J Transl Med. 2004, 2: 19-29. 10.1186\/1479-5876-2-19.","journal-title":"J Transl Med"},{"key":"254_CR13","first-page":"9","volume":"7","author":"A Uenaka","year":"2007","unstructured":"Uenaka A, Wada H, Isobe M, Saika T, Tsuji K, Sato E, Sato A, Noguchi Y, Kawabata R, Yasuda T, Doki Y, Kumon H, Iwatsuki K, Shiku H, Monden M, Jungbluth AA, Ritter G, Murphy R, Hoffman E, Old LJ, Nakayama E: T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. Cancer Immun. 2007, 7: 9-19.","journal-title":"Cancer Immun"},{"key":"254_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1349-7006.2007.00429.x","volume":"98","author":"H Yanagimoto","year":"2007","unstructured":"Yanagimoto H, Mine T, Yamamoto K, Satoi S, Terakawa N, Takahashi K, Nakahara K, Honma S, Tanaka M, Mizoguchi J, Yamada A, Oka M, Kamiyama Y, Itoh K, Takai S: Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer. Cancer Sci. 2007, 98: 605-611. 10.1111\/j.1349-7006.2007.00429.x.","journal-title":"Cancer Sci"},{"key":"254_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm0897-917","volume":"3","author":"G Ambrosini","year":"1997","unstructured":"Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997, 3: 917-921. 10.1038\/nm0897-917.","journal-title":"Nat Med"},{"key":"254_CR16","first-page":"1731","volume":"8","author":"Y Hirohashi","year":"2002","unstructured":"Hirohashi Y, Torigoe T, Maeda A, Nabeta Y, Kamiguchi K, Sato T, Yoda J, Ikeda H, Hirata K, Yamanaka N, Sato N: An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Clin Cancer Res. 2002, 8: 1731-1739.","journal-title":"Clin Cancer Res"},{"key":"254_CR17","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1158\/1078-0432.CCR-03-0817","volume":"11","author":"S Idenoue","year":"2005","unstructured":"Idenoue S, Hirohashi Y, Torigoe T, Sato Y, Tamura Y, Hariu H, Yamamoto M, Kurotaki T, Tsuruma T, Asanuma H, Kanaseki T, Ikeda H, Kashiwagi K, Okazaki M, Sasaki K, Sato T, Ohmura T, Hata F, Yamaguchi K, Hirata K, Sato N: A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins. Clin Cancer Res. 2005, 11: 1474-1482. 10.1158\/1078-0432.CCR-03-0817.","journal-title":"Clin Cancer Res"},{"key":"254_CR18","first-page":"4056","volume":"59","author":"D Yang","year":"1999","unstructured":"Yang D, Nakao M, Shichijo S, Sasatomi T, Takasu H, Matsumoto H, Mori K, Hayashi A, Yamana H, Shirouzu K: Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients. Cancer Res. 1999, 59: 4056-4063.","journal-title":"Cancer Res"},{"key":"254_CR19","first-page":"4830","volume":"60","author":"S Nishizaka","year":"2000","unstructured":"Nishizaka S, Gomi S, Harada K, Oizumi K, Itoh K, Shichijo S: A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma. Cancer Res. 2000, 60: 4830-4837.","journal-title":"Cancer Res"},{"key":"254_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/ijc.1205","volume":"92","author":"MK Gjertsen","year":"2001","unstructured":"Gjertsen MK, Buanes T, Rosseland AR, Bakka A, Gladhaug I, Soreide O, Eriksen JA, Moller M, Baksaas I, Lothe RA, Saeterdal I, Gaudernack G: Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma. Int J Cancer. 2001, 92: 441-450. 10.1002\/ijc.1205.","journal-title":"Int J Cancer"},{"key":"254_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1182\/blood-2002-08-2554","volume":"15","author":"SM Schmidt","year":"2003","unstructured":"Schmidt SM, Schag K, Muller MR, Weck MM, Appel S, Kanz L, Grunebach F, Brossart P: Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells. Blood. 2003, 15: 571-576. 10.1182\/blood-2002-08-2554.","journal-title":"Blood"},{"key":"254_CR22","first-page":"4845","volume":"60","author":"M Schmitz","year":"2000","unstructured":"Schmitz M, Diestelkoetter P, Weigle B, Schmachtenberg F, Stevanovic S, Ockert D, Rammensee HG, Rieber EP: Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res. 2000, 60: 4845-4849.","journal-title":"Cancer Res"},{"key":"254_CR23","first-page":"869","volume":"61","author":"MH Andersen","year":"2001","unstructured":"Andersen MH, Becker JC, Straten P: Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients. Cancer Res. 2001, 61: 869-872.","journal-title":"Cancer Res"},{"key":"254_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1158\/1078-0432.CCR-06-1722","volume":"13","author":"M Grube","year":"2007","unstructured":"Grube M, Moritz S, Obermann EC, Rezvani K, Mackensen A, Andressen R, Holler E: CD8+ Tcell reactive to survivin antigen in patients with multiple myeloma. Clin Cacncer Res. 2007, 13: 1053-1060. 10.1158\/1078-0432.CCR-06-1722.","journal-title":"Clin Cacncer Res"},{"key":"254_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1479-5876-4-38","volume":"4","author":"MH Andersen","year":"2006","unstructured":"Andersen MH, Soerensen RB, Becker JC, Straten P: HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer. J Transl Med. 2006, 4: 38-10.1186\/1479-5876-4-38.","journal-title":"J Transl Med"},{"key":"254_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrd1717","volume":"4","author":"MH Andersen","year":"2005","unstructured":"Andersen MH, Becker JC, Straten PT: Regulators of apoptosis: suitable targets for immune therapy of cancer. Nat Rev Drug Discov. 2005, 4: 399-409. 10.1038\/nrd1717.","journal-title":"Nat Rev Drug Discov"},{"key":"254_CR27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/pros.20404","volume":"66","author":"S Fuessel","year":"2006","unstructured":"Fuessel S, Meye A, Schmitz M, Zastrow S, Linne C, Richter K, Lobel B, Hakenberg OW, Hoelig K, Rieber EP, Wirth MP: Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial. Prostate. 2006, 66: 811-821. 10.1002\/pros.20404.","journal-title":"Prostate"},{"key":"254_CR28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/0008-5472.553.65.2","volume":"65","author":"R Xiang","year":"2005","unstructured":"Xiang R, Mizutani N, Luo Y, Chiodoni C, Zhou H, Mizutani M, Ba Y, Becker JC, Reisfeld RA: A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res. 2005, 65: 553-561.","journal-title":"Cancer Res"},{"key":"254_CR29","first-page":"5964","volume":"61","author":"MH Andersen","year":"2001","unstructured":"Andersen MH, Pedersen LO, Capeller B, Brocker EB, Becker JC, Straten PT: Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients. Cancer Res. 2001, 61: 5964-5968.","journal-title":"Cancer Res"},{"key":"254_CR30","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/ijc.11634","volume":"108","author":"S Reker","year":"2004","unstructured":"Reker S, Becker JC, Svane IM, Ralfkiaer E, Straten PT, Andersen MH: HLA-B35-restricted immune responses against survivin in cancer patients. Int J Cancer. 2004, 108: 937-941. 10.1002\/ijc.11634.","journal-title":"Int J Cancer"},{"key":"254_CR31","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/sj.leu.2403029","volume":"17","author":"S Shangary","year":"2003","unstructured":"Shangary S, Johnson DE: Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family. Leukemia. 2003, 17: 1470-1481. 10.1038\/sj.leu.2403029.","journal-title":"Leukemia"},{"key":"254_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4161\/cbt.3.2.611","volume":"3","author":"S Reker","year":"2004","unstructured":"Reker S, Meier A, Holten-Andersen L, Svane IM, Becker JC, Straten P, Andersen MH: Identification of novel survivin-derived CTL epitopes. Cancer Biol Ther. 2004, 3: 173-179.","journal-title":"Cancer Biol Ther"},{"key":"254_CR33","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1038\/sj.leu.2403510","volume":"18","author":"S Siegel","year":"2004","unstructured":"Siegel S, Steinmann J, Schmitz N, Stuhlmann R, Dreger P, Zeis M: Identification of a survivin-derived peptide that induces HLA-A0201-restricted antileukemia cytotoxic T lymphocytes. Leukemia. 2004, 18: 2046-2047. 10.1038\/sj.leu.2403510.","journal-title":"Leukemia"},{"key":"254_CR34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrd1717","volume":"4","author":"MH Andersen","year":"2005","unstructured":"Andersen MH, Becker JC, Straten P: Regulations of apoptosis: suitable targets for immune therapy of cancer. Nat Rev Drug Discov. 2005, 4: 399-409. 10.1038\/nrd1717.","journal-title":"Nat Rev Drug Discov"},{"key":"254_CR35","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00262-005-0102-x","volume":"55","author":"M Wobser","year":"2006","unstructured":"Wobser M, Keikavoussi P, Kunzmann V, Weininger M, Andersen MH, Becker JC: Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin. Cancer Immunol Immunother. 2006, 55: 1294-1298. 10.1007\/s00262-005-0102-x.","journal-title":"Cancer Immunol Immunother"},{"key":"254_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2407-6-45","volume":"6","author":"M Espinosa","year":"2006","unstructured":"Espinosa M, Cantu D, Herrera N, Lopez CM, De la Garza JG, Maldonado V, Melendez-Zajgla J: Inhibitors of apoptosis proteins in human cervical cancer. BMC Cancer. 2006, 6: 45-54. 10.1186\/1471-2407-6-45.","journal-title":"BMC Cancer"},{"key":"254_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11596-007-0411-8","volume":"27","author":"Z Cheng","year":"2007","unstructured":"Cheng Z, Hu L, Fu W, Zhang Q, Liao X: Expression of survivin and its splice variants in gastric cancer. J Huazhong Univ Sci Technolog Med Sci. 2007, 27: 393-398. 10.1007\/s11596-007-0411-8.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"254_CR38","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1525-1438.2007.00833.x","volume":"17","author":"H Futakuchi","year":"2007","unstructured":"Futakuchi H, Ueda M, Kanda K, Fujino K, Yamaguchi H, Noda S: Transcriptional expression of survivin and its splice variants in cervical carcinoma. Int J Gynecol Cancer. 2007, 17: 1092-1098.","journal-title":"Int J Gynecol Cancer"},{"key":"254_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.lungcan.2004.10.017","volume":"48","author":"Y Ichiki","year":"2005","unstructured":"Ichiki Y, Hanagiri T, Takenoyama M, Baba T, Fukuyama T, Nagata Y, Mizukami M, So T, Sugaya M, Yasuda M, So T, Sugio K, Yasumoto K: Tumor specific expression survivin-2B in lung cancer as a novel target of immunotherapy. Lung Cancer. 2005, 48: 281-289. 10.1016\/j.lungcan.2004.10.017.","journal-title":"Lung Cancer"},{"key":"254_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/ijc.10450","volume":"100","author":"C Mahotka","year":"2002","unstructured":"Mahotka C, Krieg T, Krieg A, Wenzel M, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD: Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int J Cancer. 2002, 100: 30-36. 10.1002\/ijc.10450.","journal-title":"Int J Cancer"},{"key":"254_CR41","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3171\/jns.2003.99.4.0738","volume":"99","author":"Y Yamada","year":"2003","unstructured":"Yamada Y, Kuroiwa T, Nakagawa T, Kajimoto Y, Dohi T, Azuma H, Tsuji M, Kami K, Miyatake S: Transcriptional expression of survivin and its splice variants in brain tumors in humans. J Neurosurg. 2003, 99: 738-745.","journal-title":"J Neurosurg"},{"key":"254_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/sj.onc.1209784","volume":"11","author":"F Vegran","year":"2007","unstructured":"Vegran F, Boidot R, Oudin C, Defrain C, Rebucci M, Lizard-Nacol S: Association of p53 gene alterations with the expression of antiapoptosis survivin splice variants in breast cancer. Oncogene. 2007, 11: 290-297. 10.1038\/sj.onc.1209784.","journal-title":"Oncogene"},{"key":"254_CR43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nm0398-328","volume":"4","author":"FO Nestle","year":"1998","unstructured":"Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D: Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med. 1998, 4: 328-332. 10.1038\/nm0398-328.","journal-title":"Nat Med"},{"key":"254_CR44","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/pros.20539","volume":"67","author":"B Hildenbrand","year":"2007","unstructured":"Hildenbrand B, Sauer B, Kalis O, Stoll C, Freudenberg MA, Niedermann G, Giesler JM, Juttner E, Peters JH, Haring B, Leo R, Unger C, Azemar M: Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells \u2013 a pilot study. Prostate. 2007, 67: 500-508. 10.1002\/pros.20539.","journal-title":"Prostate"},{"key":"254_CR45","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1158\/0008-5472.CAN-04-3912","volume":"65","author":"Y Wu","year":"2005","unstructured":"Wu Y, Wan T, Zhou X, Wang B, Yang F, Li N, Chen G, Dai S, Liu S, Zhang M, Cao X: Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine. Cancer Res. 2005, 65: 4947-4954. 10.1158\/0008-5472.CAN-04-3912.","journal-title":"Cancer Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-6-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1479-5876-6-24\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-6-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T07:13:50Z","timestamp":1684394030000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-6-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,10]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-6-24","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,10]]},"article-number":"24"}}